Brouhaha’s latest production ‘Firebrand’ impresses at Cannes Film Festival
Brouhaha’s latest project impresses at prestigious Cannes Film Festival.
Brouhaha’s latest project impresses at prestigious Cannes Film Festival.
This encouraging research programme stems from a collaboration Destiny Pharma has with SporeGen Limited
The collaboration will see a new Phase 1b trial undertaken, investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma (ACC), a rare and aggressive type of cancer
The grant from the Medical Technology Enterprise Consortium (MTEC) will support the continued development of its fully portable handheld DeepView device
Brouhaha continue their progress with prestigious inclusion.
It is hoped that these reagents will help combat the growing wave of deaths in North America attributable to synthetic opioids
The initial administration of Arecor’s insulin candidate to a patient marks a significant step forward in the quest to transform the management of type 2 diabetes. Arecor’s innovative therapy has the potential to revolutionise the way this disease is treated, offering new hope and improved outcomes for individuals living with diabetes.